Philips, Infraredx ink deal for resale of coronary artery disease imaging system
Royal Philips (Andover, MA) and Infraredx (Burlington, MA) have signed a non-exclusive resale agreement for Infraredxâs TVC Imaging System. Under the terms of the agreement, Philips will sell the system alongside its Allura interventional x-ray systems in North America and Europe, expanding its interventional cardiology portfolio of advanced live image guidance solutions, clinical informatics, and interventional tools.
Related: Intravascular imaging system detects cholesterol signature in heart attack patients
Additional catheter-based intravascular imaging technologies, such as the TVC Imaging System, are being used to assess the structure and composition of plaques from within the blood vessel for coronary artery disease (CAD), and to guide the interventional treatment for better procedural outcomes.
The TVC Imaging System is an intravascular imaging system that integrates near-infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology and intravascular ultrasound (IVUS) imaging to visualize the presence of plaques, quantify the degree of vessel stenosis (narrowing), and identify plaques prone to rupturing and causing dangerous blockages.
In March 2013, the two companies launched a software solution to enable the integration of the TVC Imaging System with Philipsâ Allura Xper and AlluraClarity interventional x-ray systems. The software facilitates setup of the TVC Imaging System in conjunction with the Allura systems, and allows clinicians tableside control of the TVC Imaging System using the Allura system controls.
Clinicians can view a TVC composite image, which shows both the NIR spectroscopy image and the IVUS image, alongside the coronary angiogram (a contrast-enhanced x-ray image of the coronary arteries) on the Allura monitors. The TVC composite image boosts visualization of lipid core plaques, which are known to cause complications in percutaneous coronary intervention (PCI) procedures and suspected of being the principal cause of most heart attacks.
-----
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Subscribe now to BioOptics World magazine; it's free!
BioOptics World Editors
We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)